Wednesday, March 1, 2017

NEURALSTEM ANNOUNCES PUBLICATION OF NSI-189 PRECLINICAL DATA IN JOURNAL OF CELLULAR PHYSIOLOGY

-NSI-189 Showed Durable Functional Recovery in a Rodent Model of Ischemic Stroke-

-NSI-189 Promoted Synaptic Remodeling After Stroke-

GERMANTOWN, Md., March 1 (Bernama-GLOBE NEWSWIRE) -- 
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announced the recent publication of preclinical data on NSI-189 in Journal of Cellular Physiology.  The study demonstrated that NSI-189 improved behavioral function recovery and enhanced hippocampal synaptic plasticity in stroke-induced animals during the 12-week treatment period, which was maintained up to 24 weeks post-stroke.


No comments:

Post a Comment